Cargando…
A novel classification of HCC basing on fatty-acid-associated lncRNA
Aberrant long noncoding RNA (lncRNA) expression and fatty acid signaling dysfunction both contribute to hepatocellular carcinoma (HCC) occurrence and development. However, the relationship and interaction mechanism between lncRNAs and fatty acid signaling in HCC remain unclear. Data regarding RNA ex...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640627/ https://www.ncbi.nlm.nih.gov/pubmed/36344648 http://dx.doi.org/10.1038/s41598-022-23681-0 |
_version_ | 1784825898031120384 |
---|---|
author | Xu, Yating Yu, Xiao Zhang, Qiyao He, Yuting Guo, Wenzhi |
author_facet | Xu, Yating Yu, Xiao Zhang, Qiyao He, Yuting Guo, Wenzhi |
author_sort | Xu, Yating |
collection | PubMed |
description | Aberrant long noncoding RNA (lncRNA) expression and fatty acid signaling dysfunction both contribute to hepatocellular carcinoma (HCC) occurrence and development. However, the relationship and interaction mechanism between lncRNAs and fatty acid signaling in HCC remain unclear. Data regarding RNA expression and clinical outcomes for patients with HCC were obtained from The Cancer Genome Atlas (TCGA), HCCDB, and the Gene Expression Omnibus (GEO) databases. Hallmark pathways were identified using the single-sample gene set enrichment analysis (ssGSEA) method. ConsensusClusterPlus was used to establish a consistency matrix for classifying samples into three subtypes. A risk signature was established, and predictive values for key lncRNAs related to prognosis were evaluated using Kaplan–Meier analysis and receiver operating characteristic curves. The ESTIMATE algorithm, MCP-Counter, and ssGSEA were used to evaluate the characteristics of the tumor immune microenvironment. The CTRP2.0 and PRISM were used to analyze drug sensitivity in HCC subtypes. We discovered seven fatty-acid-associated lncRNAs with predictive prognostic capabilities, including TRAF3IP2-AS1, SNHG10, AL157392.2, LINC02641, AL357079.1, AC046134.2, and A1BG-AS. Three subtypes were obtained, which presented with differences in prognosis, clinical information, mutation features, pathway traits, immune characteristics, and drug sensitivity. The seven key lncRNAs identified in this study might serve as promising biomarkers for predicting prognosis in patients with HCC, and the three HCC subtypes classified according to lncRNA expression profiles could improve HCC classification. |
format | Online Article Text |
id | pubmed-9640627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96406272022-11-15 A novel classification of HCC basing on fatty-acid-associated lncRNA Xu, Yating Yu, Xiao Zhang, Qiyao He, Yuting Guo, Wenzhi Sci Rep Article Aberrant long noncoding RNA (lncRNA) expression and fatty acid signaling dysfunction both contribute to hepatocellular carcinoma (HCC) occurrence and development. However, the relationship and interaction mechanism between lncRNAs and fatty acid signaling in HCC remain unclear. Data regarding RNA expression and clinical outcomes for patients with HCC were obtained from The Cancer Genome Atlas (TCGA), HCCDB, and the Gene Expression Omnibus (GEO) databases. Hallmark pathways were identified using the single-sample gene set enrichment analysis (ssGSEA) method. ConsensusClusterPlus was used to establish a consistency matrix for classifying samples into three subtypes. A risk signature was established, and predictive values for key lncRNAs related to prognosis were evaluated using Kaplan–Meier analysis and receiver operating characteristic curves. The ESTIMATE algorithm, MCP-Counter, and ssGSEA were used to evaluate the characteristics of the tumor immune microenvironment. The CTRP2.0 and PRISM were used to analyze drug sensitivity in HCC subtypes. We discovered seven fatty-acid-associated lncRNAs with predictive prognostic capabilities, including TRAF3IP2-AS1, SNHG10, AL157392.2, LINC02641, AL357079.1, AC046134.2, and A1BG-AS. Three subtypes were obtained, which presented with differences in prognosis, clinical information, mutation features, pathway traits, immune characteristics, and drug sensitivity. The seven key lncRNAs identified in this study might serve as promising biomarkers for predicting prognosis in patients with HCC, and the three HCC subtypes classified according to lncRNA expression profiles could improve HCC classification. Nature Publishing Group UK 2022-11-07 /pmc/articles/PMC9640627/ /pubmed/36344648 http://dx.doi.org/10.1038/s41598-022-23681-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Xu, Yating Yu, Xiao Zhang, Qiyao He, Yuting Guo, Wenzhi A novel classification of HCC basing on fatty-acid-associated lncRNA |
title | A novel classification of HCC basing on fatty-acid-associated lncRNA |
title_full | A novel classification of HCC basing on fatty-acid-associated lncRNA |
title_fullStr | A novel classification of HCC basing on fatty-acid-associated lncRNA |
title_full_unstemmed | A novel classification of HCC basing on fatty-acid-associated lncRNA |
title_short | A novel classification of HCC basing on fatty-acid-associated lncRNA |
title_sort | novel classification of hcc basing on fatty-acid-associated lncrna |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640627/ https://www.ncbi.nlm.nih.gov/pubmed/36344648 http://dx.doi.org/10.1038/s41598-022-23681-0 |
work_keys_str_mv | AT xuyating anovelclassificationofhccbasingonfattyacidassociatedlncrna AT yuxiao anovelclassificationofhccbasingonfattyacidassociatedlncrna AT zhangqiyao anovelclassificationofhccbasingonfattyacidassociatedlncrna AT heyuting anovelclassificationofhccbasingonfattyacidassociatedlncrna AT guowenzhi anovelclassificationofhccbasingonfattyacidassociatedlncrna AT xuyating novelclassificationofhccbasingonfattyacidassociatedlncrna AT yuxiao novelclassificationofhccbasingonfattyacidassociatedlncrna AT zhangqiyao novelclassificationofhccbasingonfattyacidassociatedlncrna AT heyuting novelclassificationofhccbasingonfattyacidassociatedlncrna AT guowenzhi novelclassificationofhccbasingonfattyacidassociatedlncrna |